Importantly, the expression levels of porimin, ERO1, ATF4 and CHOP were significantly upregulated (Fig. 6D, E), serving as robust indicators of ER stress-mediated oncosis triggered by AD treatment. Here, ATF4 is linked to Alzheimer disease.